Invention Grant
US09031649B2 Reducing inappropriate delivery of therapy for suspected non-lethal arrhythmias
有权
减少怀疑非致命性心律失常的不适当的治疗方法
- Patent Title: Reducing inappropriate delivery of therapy for suspected non-lethal arrhythmias
- Patent Title (中): 减少怀疑非致命性心律失常的不适当的治疗方法
-
Application No.: US14088685Application Date: 2013-11-25
-
Publication No.: US09031649B2Publication Date: 2015-05-12
- Inventor: Kevin T. Ousdigian
- Applicant: Medtronic, Inc.
- Applicant Address: US MN Minneapolis
- Assignee: Medtronic, Inc.
- Current Assignee: Medtronic, Inc.
- Current Assignee Address: US MN Minneapolis
- Agent Michael J. Ostrom
- Main IPC: A61N1/362
- IPC: A61N1/362 ; A61N1/372 ; A61B5/0464 ; A61N1/39 ; A61B5/00

Abstract:
An implantable medical device (IMD) identifies suspected non-lethal ventricular arrhythmia, and takes one or more actions in response to the identification to avoid or delay delivery of a defibrillation or cardioversion shock. The IMD employs number of intervals to detect (NID) thresholds for detection of ventricular arrhythmias. When a NID threshold is met, the IMD determines whether the ventricular rhythm is a suspected non-lethal rhythm despite satisfying a NID threshold. In some embodiments, the IMD increases the NID threshold, i.e., extends the time for detection, in response to identifying a rhythm as a suspected non-lethal rhythm, and monitors subsequent ventricular beats to determine if the increased NID threshold is met before detecting a ventricular arrhythmia and delivering therapy. The IMD can determine whether a rhythm is a suspected non-lethal arrhythmia by, for example, comparing the median ventricular cycle length (VCL) to the median atrial cycle length (ACL).
Public/Granted literature
- US20140088662A1 REDUCING INAPPROPRIATE DELIVERY OF THERAPY FOR SUSPECTED NON-LETHAL ARRHYTHMIAS Public/Granted day:2014-03-27
Information query
IPC分类: